1. Characteristic 1: a compound represented by (1) a formula or a pharmaceutically acceptable salt of the compound, [where l represents - nr83099],-O-O-SR⁵ represents a hydrogen atom or a C₁₋₆ alkyl group substituted with zero to two -OH groups, zero to two C₁₋₈ alkoxy groups and zero to six fluorine atoms； R¹ represents a C₁₋₈ alkyl group,C₃₋₁₂ cycloalkyl,(cycloquilo c8323-318321； 832221) - asphalt c83231；Isopropene-c832131-832626 of 4-12 members (4-12 members)；aryl C₆₋₁₀,(Aril C) -alquilo C5-10 membered heteroaryl, (5-10 membered heteroaryl) -C₁₋₆ alkyl,C₁₋₈ alkylsulfonyl or C₁₋₈ acyl；Each group containing heteromorphic atoms represented by R1 contains one to four heteromorphic atoms selected from oxygen, sulfur and nitrogen atoms； R1 can be replaced by one to six substitutes selected from halogen atom group, which are composed of one halogen atom = = - o-oh-cn-cooh-cour8310；-R8311；a C₃₋₆ cycloalkyl group substituted with zero to two -OH groups, zero to two C₁₋₈ alkoxy groups and zero to six fluorine atoms, a 3 to 10 membered heterocyclyl group substituted with zero to two -OH groups, zero to two C₁₋₈ alkoxy groups and zero to six fluorine atoms, a C₁₋₈ acyl group substituted with zero to two -OH groups, zero to two C₁₋₈ alkoxy groups and zero to six fluorine atoms, and a C₁₋ alkoxy group ₈ substituted with zero to two -OH groups, zero to two C₁₋₈ alkoxy groups and zero to six fluorine atoms； R⁶ and R⁷,each independently represents a C₁₋₆ alkyl group substituted with zero to two -OH groups, zero to two C₁₋₈ alkoxy groups and zero to six fluorine atoms； R² represents a C₁₋₈ alkyl group,C₃₋₈ cycloalkyl,4-6 members or c832131 and 832828；-Coordination 831222；or -CONR⁹R¹⁰；e. C8321c83318328 in each group；and zero to three fluorine atoms, and zero to five fluorine atoms； R² is neither an unsubstituted C₁₋₈ alkyl, nor unsubstituted C₃₋₈ cycloalkyl, nor a trifluoromethyl group； R⁸,R8313 and r183044,each independently represents a hydrogen atom or a C₁₋₈ alkyl group；the 4 t
